Skip to main content

Advertisement

Log in

68Gallium-Arginine-Glycine-Aspartic Acid and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Chondroblastic Osteosarcoma of the Skull

  • Interesting Image
  • Published:
Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

We report the case of a 32 year-old male with Chondroblastic Osteosarcoma of the skull, which was imaged with both 18[F]fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) and 68Gallium-arginine-glycine-aspartic acid (68Ga-RGD) PET/CT. The 18F-FDG PET/CT did not demonstrate the tumour, whereas the 68Ga-RGD PET/CT clearly depicted a left-sided frontal tumour. 68Ga-RGD PET/CT may be a clinically useful imaging modality for early detection of recurrent osteosarcoma, considering the limitations of 18F-FDG PET in a setting of low glycolytic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Abbreviations

PET/CT:

Positron emission tomography/computed tomography

68Ga-RGD:

68Gallium-arginine-glycine-aspartic acid

18F-FDG:

18[F]fluorodeoxyglucose

References

  1. Beer AJ, Kessler H, Wester HJ, Schwaiger M. PET imaging of integrin αvβ3 expression. Theranostics. 2011;1:48–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Cai H, Conti PS. RGD-based PET tracers for imaging receptor integrin αvβ3 expression. J Labelled Comp Radiopharm. 2013;56:264–79.

    Article  CAS  PubMed  Google Scholar 

  3. Pedersen MW, Holm S, Lund EL, et al. Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro. Neoplasia. 2001;3:80–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Quartuccio N, Treglia G, Salsano M, et al. The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma. Radiol Oncol. 2013;47:97–102.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Cheng W, Wu Z, Liang S, et al. Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancer. PLoS One. 2014;9:e100521.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Paik JY, Ko BH, Choe YS, et al. PMA-enhanced neutrophil [18F]FDG uptake is independent of integrin occupancy but requires PI3K activity. Nucl Med Biol. 2005;32:561–6.

    Article  CAS  PubMed  Google Scholar 

  7. Im HJ, Kim TS, Park SY, et al. Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma. Eur J Nucl Med Mol Imaging. 2012;39:39–49.

    Article  CAS  PubMed  Google Scholar 

  8. Elisabeth Blom E, Velikyan I, Sergio Estrada S, et al. (68)Ga-Labeling of RGD peptides and biodistribution. Int J Clin Exp Med. 2012;5:165–72.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

Ms. I Schoeman and Dr. B Mokaleng for their contributions to ensuring quality control of Ga68 radiopharmaceuticals. We thank Prof. E Raubenheimer who provided histology images on behalf of George Mukhari Academic Hospital.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mike Sathekge.

Ethics declarations

Conflict of Interest

Akintunde Orunmuyi, Moshe Modiselle, Thabo Lengana, Thomas Ebenhan, Mariza Vorster, and Mike Sathekge, declare that they have no conflict of interest.

Ethical Statement

This study was approved by the University of Pretoria’s Research Ethics committee and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Orunmuyi, A., Modiselle, M., Lengana, T. et al. 68Gallium-Arginine-Glycine-Aspartic Acid and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Chondroblastic Osteosarcoma of the Skull. Nucl Med Mol Imaging 51, 271–273 (2017). https://doi.org/10.1007/s13139-016-0400-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13139-016-0400-6

Keywords

Navigation